STOCK TITAN

Radnet SEC Filings

RDNT NASDAQ

Welcome to our dedicated page for Radnet SEC filings (Ticker: RDNT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

The RadNet, Inc. (RDNT) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as a NASDAQ-listed issuer. RadNet files reports and current updates with the U.S. Securities and Exchange Commission in connection with its operations as a national provider of freestanding, fixed-site diagnostic imaging services and as the parent of the DeepHealth digital health division.

Among the filings that investors commonly review are annual reports on Form 10-K and quarterly reports on Form 10-Q, which present information on RadNet’s Imaging Center and Digital Health reportable segments, revenue composition, imaging volumes, liquidity and capital structure. Current reports on Form 8-K are used to disclose specific material events, such as the release of quarterly financial results or the filing of a prospectus supplement under an automatic shelf registration statement. For example, RadNet has filed 8-Ks to furnish press releases detailing financial results for quarters ended June 30, 2025 and September 30, 2025, and to report the filing of a prospectus supplement registering shares of common stock for resale by selling stockholders.

Through this filings page, users can also monitor documents related to securities offerings, including prospectus supplements and associated legal opinions, as well as other disclosures that may affect the company’s capital markets activity. Forms related to insider transactions, such as Form 4, and proxy materials on executive compensation and governance are part of the broader SEC record and can be relevant for understanding management incentives and ownership changes.

Stock Titan enhances access to these filings by pairing real-time updates from the SEC’s EDGAR system with AI-powered summaries that explain key points in plain language. This can help readers interpret lengthy documents such as 10-K and 10-Q reports, understand the implications of 8-K announcements and quickly identify notable items in RadNet’s regulatory history. For anyone analyzing RDNT, the SEC filings page is a central source for official, time-stamped information on the company’s financial condition, segment performance and capital markets activity.

Rhea-AI Summary

RTW Investments, LP and Roderick Wong, M.D. report beneficial ownership of 3,938,500 shares of RadNet, Inc. common stock, representing 5.1% of the company’s outstanding shares. This stake relates to RadNet’s common stock with a $0.0001 par value.

The ownership is held through certain RTW-managed funds, with RTW Investments acting as investment adviser and Dr. Wong as Managing Partner and Chief Investment Officer. Voting and dispositive power over all 3,938,500 shares is shared. The investors state the shares were acquired and are held in the ordinary course of business, not to change or influence control of RadNet.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.21%
Tags
ownership
-
Rhea-AI Summary

RadNet, Inc. has registered for resale up to 190,924 shares of its common stock through a prospectus supplement to its automatic shelf registration statement. These shares will be issued to the Cimar Sellers or their designees as the non-cash portion of the consideration for RadNet’s acquisition of all shares in Cimar (UK) Limited, completed on November 10, 2025. The acquisition was executed under a Share Purchase Agreement between the Cimar Sellers and DH AI International Holdings, B.V., RadNet’s wholly owned Dutch subsidiary. RadNet also filed a legal opinion from Reed Smith LLP on the validity of the registered securities as an exhibit.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

RadNet, Inc. is registering the resale of up to 190,924 shares of common stock issued to the former owners of Cimar (UK) Limited as the non-cash portion of the purchase price under a November 10, 2025 share purchase agreement.

The Cimar Sellers received stock equal to half of approximately £20.1 million due at closing, and this filing satisfies their registration rights so they can sell those shares over time. RadNet will not receive any proceeds from these sales, though it is paying the registration and related expenses. The selling stockholders may dispose of shares through various public or private sale methods at market, fixed, or negotiated prices.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
Rhea-AI Summary

RadNet, Inc. expanded its executive leadership team and adjusted compensation for key executives. The company promoted Stephen Forthuber to President and Chief Executive Officer, Eastern Operations, and Norman Hames to President and Chief Executive Officer, Western Operations. Mital Patel was promoted to Executive Vice President and Chief Operating Officer.

In connection with these changes and routine compensation updates effective January 1, 2026, the Compensation Committee approved new annual base salaries of $950,000 for Mr. Forthuber, $950,000 for Mr. Hames, and $925,000 for Mr. Patel. The committee also set annual base salaries of $850,000 for Executive Vice President and Chief Financial Officer Mark Stolper and $850,000 for Cornelis Wesdorp, President and Chief Executive Officer, Digital Health. All other terms of their existing employment agreements remain unchanged.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.23%
Tags
current report
-
Rhea-AI Summary

RadNet, Inc. reported that its executive vice president and chief financial officer exercised an employee stock option and acquired additional common shares. On December 10, 2025, the officer exercised an employee stock option (right to buy) to purchase 35,703 shares of common stock at a price of $6.07 per share, resulting in the same number of shares being acquired.

After this transaction, the officer directly owned 103,715 shares of RadNet common stock. The option was originally granted on January 4, 2016 for up to 35,703 shares and vested in three equal annual installments, subject to the officer’s continued service.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

RadNet, Inc. reported an insider stock transaction by an executive who serves as Executive Vice President and Chief Legal Officer. On 12/10/2025, this reporting person exercised employee stock options to acquire 3,396 shares of RadNet common stock at an exercise price of $29.44 per share, bringing their directly held common stock to 71,577 shares.

The exercised options are part of a grant originally issued on January 4, 2022 for up to 29,140 shares, subject to time-based vesting. One-third vested on January 4, 2022, with the remaining two-thirds vesting in three equal installments on January 3, 2023, January 3, 2024, and January 3, 2025. After this transaction, the reporting person continues to beneficially own 15,556 employee stock options, which are scheduled to expire on January 3, 2032.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

RadNet, Inc. reported that a company officer serving as executive vice president of financial planning and chief accounting officer disposed of shares of common stock through a gift on December 3, 2025. The officer transferred 630 shares of RadNet common stock at a reported price of $0, consistent with a non-cash gift. After this transaction, the officer directly beneficially owned 179,508 shares of RadNet common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

RadNet, Inc. (RDNT) disclosed that its President, CEO and director exercised previously granted stock options and acquired additional common shares. On 11/19/2025, he exercised options to buy 103,969 shares of common stock at an exercise price of $18.64 per share, increasing his directly held stake to 322,420 shares. On the same date, he exercised another block of options for 25,992 shares at $18.64, bringing his direct holdings to 348,412 shares.

The filing shows an additional 20,000 shares of RadNet common stock held indirectly through his spouse. The options exercised were originally granted on January 3, 2023 as retention awards, with vesting tied to continued service and, for one grant, to RadNet’s fiscal year 2023 performance, which resulted in 100% performance-based vesting.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

RadNet, Inc. (RDNT) executive EVP of Financial Planning and Chief Accounting Officer reported multiple open-market sales of company common stock. On 11/17/2025, the executive sold 25,000 shares at a weighted average price of $76.06. On 11/18/2025, a further 9,920 shares were sold at a weighted average price of $80.00, followed by 15,080 shares sold on 11/19/2025 at a weighted average price of $80.05. After these transactions, the reporting person directly beneficially owns 180,138 shares of RadNet common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

RadNet, Inc. executive vice president of mergers and acquisitions reported a stock gift on a Form 4. On 11/13/2025, the officer disposed of 3,000 shares of RadNet common stock in a transaction coded “G,” which indicates a bona fide gift. Following this transaction, the reporting person directly held 40,084 shares of RadNet common stock. The filing reflects an insider ownership change rather than any corporate action by the company.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.75%
Tags
insider

FAQ

What is the current stock price of Radnet (RDNT)?

The current stock price of Radnet (RDNT) is $69.81 as of February 27, 2026.

What is the market cap of Radnet (RDNT)?

The market cap of Radnet (RDNT) is approximately 5.6B.

RDNT Rankings

RDNT Stock Data

5.58B
67.32M
Diagnostics & Research
Services-medical Laboratories
Link
United States
LOS ANGELES

RDNT RSS Feed